drugset / Trial / NCT05813561
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy, safety, and cost-effectiveness of DWP14012 40 mg compared to esomeprazole magnesium enteric-coated tablets for the treatment of reflux esophagitis.
Timeline
- Start
- 2021-12-30
- Primary completion
- 2022-07-23
- Completion
- 2023-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABEPRAZAN | Small molecule | 40 mg | — |